TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD -37.31 M

TELA Bio, Inc. EBITDA is USD -37.31 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 9.23% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -34.16 M, a -14.22% change year over year.
  • TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -39.83 M, a 25.11% change year over year.
  • TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -31.83 M, a 24.34% change year over year.
  • TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -25.60 M, a 31.06% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)